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The Tn1546-related elements of 48 Van glycopetide-resistant enterococci were compared. Ten distinct
Tn1546 types were identified with variation primarily due to IS1542 and IS1216V-like insertions. Clonal
isolates frequently differed in their Tn1546 type, indicating instability of Tn1546-related elements. A putative
hybrid promoter was identified, generated upstream of vanR by the insertion of IS1542. The presence of this
hybrid promoter was associated with constitutive expression of the van genes and elevated teicoplanin resis-
tance.
While all VanA phenotype glycopeptide-resistant entero-
cocci (GRE) share the same basic Tn1546 structure, as de-
scribed for Enterococcus faecium BM4147 (2), considerable
diversity has now been identified within Tn1546-related ele-
ments. This variation, in the form of point mutations, insertion
sequence (IS) elements, and deletions, has been exploited in
several epidemiological studies (8, 10, 13), often in combina-
tion with well-established methods (e.g., pulsed-field gel elec-
trophoresis [PFGE] and ribotyping). However, the possible
transient nature of insertion sequences has led to questions
about the suitability of this type of analysis in epidemiological
studies (4, 15). In this study, we have compared 48 VanA
enterococcal isolates by PFGE and by molecular analysis of
Tn1546-related elements.
Forty-eight clinical isolates of enterococci, collected from
eight hospitals in Scotland over a 5-year period (1995 to 1999)
were confirmed as vanA positive by PCR (5) and identified
with the AP120 Strep system (BioMerieux). Sixty-nine percent
of isolates were E. faecium, and the remainder were E. faecalis.
Vancomycin and teicoplanin MICs were determined by incor-
poration of the antimicrobial agents into Mueller-Hinton agar
(Oxoid) and inoculation of plates with approximately 104 CFU
per inocula. All 48 isolates displayed resistance levels that were
typical of the VanA phenotype. Vancomycin and teicoplanin
MICs ranged from 64 to 1,024 mg/liter and 8–128 mg/liter,
respectively.
PFGE analysis and interpretation were performed as previ-
ously described (9, 12). Following digestion with SmaI, genomic
DNA was separated by electrophoresis for 24 h at 200 V with
5- to 40-s pulse times. Discounting those isolates belonging to
a previously described outbreak strain of VanA E. faecium (3),
the 48 isolates were largely heterogeneous in nature, with only
small discrete clusters of related isolates identified. No GRE
isolated from different geographic regions of Scotland shared
PFGE patterns.
Template DNA for PCRs was prepared by the guanidium
thiocyanate extraction method (11). Long-template PCR (L-
PCR; Expand long-template PCR system; Boehringer Mann-
heim) was used according to the manufacturer’s instructions.
The inverted repeat (IR)-specific primers described previously
(16) enabled amplification of the Tn1546-related elements and
subsequent restriction fragment length polymorphism (RFLP)
analysis by ClaI digestion. Five of the 48 isolates failed to yield
an L-PCR product with the Tn1546-IR primer, suggesting that
they lacked at least one of the IRs. The loss of the left IR has
been previously described and is often associated with the
presence of IS1216V-like elements alone or in combination
with a truncated IS3-like element (6, 13). The reason for the
L-PCR failure in these five isolates was not ascertained. The
Tn1546-related elements of the remaining 43 isolates were
assigned to 10 distinct types on the basis of ClaI RFLP analysis.
Fourteen isolates harbored Tn1546 elements that were indis-
tinguishable from the prototype Tn1546 element by ClaI RFLP
analysis. The remaining 29 isolates harbored nonprototype el-
ements. Different Tn1546 types were evident in clonally related
isolates, indicating instability within Tn1546-related elements.
Such instability has been previously described (15).
Using the primers listed in Table 1, all nonprototype Tn1546-
related elements were further studied by PCR and by hybrid-
ization analysis with the ECL (enhanced chemiluminescence)
random prime labeling and detection system (Amersham Life
Sciences Ltd.). PCR products of interest were sequenced in
both directions by the dideoxy method on an ABI Prism auto-
mated sequencer. All 29 nonprototype elements harbored
IS1542 within the orf2-vanR intergenic region (nucleotide po-
sition 3932) and an IS1216V-like element within the vanX-vanY
intergenic region (nucleotide position 8839). Both IS elements
have been described previously at the same nucleotide posi-
tions (13, 15). In addition, all nonprototype Tn1546-related
elements had considerable variation within the orf1-orf2 re-
gion. Hybridization analysis, performed following BamHI di-
gestion of Tn1546-related elements, confirmed that this varia-
tion was due at least in part to the insertion of an IS1216V-like
element within the orf1-orf2 region. The precise location of the
insertion was not ascertained.
The point mutation at Tn1546 nucleotide position 8234
(G3T) within the vanX gene was screened for as described
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previously (10). This point mutation, previously associated with
porcine isolates of VanA GRE (14), was not evident in any of
the isolates studied.
Sequencing of orf2-vanR intergenic regions harboring IS1542
identified a putative hybrid promoter. The -10 TATAAT box that
forms part of the native vanR promoter proposed by Holman
et al. (7) is duplicated by the 8-bp target site duplication gen-
erated by IS1542 insertion at nucleotide position 3932. This
duplicated -10 box forms a putative promoter sequence in
conjunction with an outwardly directed -35 box (TTTACA )
located within the inverted repeat of IS1542. The impact of the
IS1542 insertion and the resulting hybrid promoter on the
expression of glycopeptide resistance was assessed by growth
curve analysis following glycopeptide challenge and by VanX
D,D-dipeptidase enzyme assays (1). Growth curves were con-
sistent with induced expression of van genes, irrespective of
whether encoded by a prototype or nonprototype Tn1546 ele-
ment. However, VanX enzyme assays revealed significant con-
stitutive expression of the van genes of nonprototype Tn1546-
related elements. Specific activities in the absence of induction
were, on average, 10-fold greater than the background expres-
sion from prototype Tn1546 elements. Constitutive expression,
which we propose is mediated by the IS1542-generated hybrid
promoter, supplemented rather than replaced the inducible
van gene expression. In addition, nonprototype Tn1546 ele-
ments conferred higher levels of teicoplanin resistance than
did prototype Tn1546 elements. While this phenomenon was
partly medium dependent (Table 2), the consistency of teico-
planin MICs conferred by prototype Tn1546 elements sug-
gested that the elevated resistance was not solely attributable
to the media used. The reason for the medium dependency is
unclear.
In conclusion, this study has revealed considerable diversity
within the Tn1546-related elements of VanA GRE in Scotland.
The types of variation witnessed were consistent with the find-
ings of previous studies. Many IS elements have the potential
to form hybrid promoters, owing to the presence of outwardly
directed -35 regions within their inverted repeats. This study
describes the first such case within the van gene cluster. We
propose that constitutive expression of the van genes from the
TABLE 1. Primers used in the analysis of Tn1546-related elementsa
Primer Sequence Coordinates Reference
Amplification
Tn1546-IR 59-GGAAAATGCGGATTTACAACGCTAAG 13–38; 10839–10814 16
orf1-f 59-GATGGTGGCTCCTTTTCC 906–923
orf1-r 59-CCATTGTTGGCAGCAGAC 1597–1580
vanR-f 59-GCCGAAAAGCCCTTTGATA 3841–3859
vanR-r 59-TCGTTCTAGTTTGGAATAGTCG 4699–4678
vanS-f 59-TAGGGTAGAGCTTCCAGCGA 5752–5771
vanH-r 59-ATTATCGTTGCCATAACGCC 6115–6096
vanX-f 59-GATGAACGCTCTCATCATGC 8448–8467
vanY-r 59-TTCCTGAGAAAACAGTGCTTCA 9138–9117
vanX1 59-ACTTGGGATAATTTCACCGG 8082–8101 8
vanX2 59-TGCGATTTTGCGCTTCATTG 8505–8486 8
Sequencing
1216V-A 59-TTGAAGATGTAAGGCAGAGC 8727–8746
1216V-B 59-AGGCTGAACTGCCTGTTGAC 8857–8838
1216V-C 59-GATCGCATAGAGGGGTGGTA 8802–8821
1542-A 59-TAGCTGTTCGAGCGAGTTCA 980–961b
1542-B 59-TCGGCAATTTCATGTTCATC 4022–4003
Hybridization
1216V-D 59-GTACAGACCGAAAACCCGAA 88–107c
1216V-E 59-GCAATTTCAGCAGGATGTGA 714–695c
a Coordinates are based on the published Tn1546 sequence (GenBank accession number M97297) unless stated otherwise. Sequencing primers were used in the
sequencing of the IS1542 and IS1216V-like elements within the orf2-vanR and vanX-vanY intergenic regions, respectively. Hybridization primers 1216V-D and 1216V-E
were used to obtain IS1216V-like-specific PCR product from which labeled probes were produced. Primers without a reference were designed by Primer3 (http:
//www.genome.wi.mit.edu.cgi-bin/primer).
b Corresponds to the published sequence of IS1542 (GenBank accession number AF114715).
c Corresponds to the published sequence of the IS1216V-like element (GenBank accession number AF093508).
TABLE 2. Summary of teicoplanin MIC data for VanA isolates with prototype and nonprototype Tn1546 elements
Medium used for
sensitivity testinga
Prototype Tn1546 Nonprototype Tn1546b
MIC50c MIC90c Rangec MIC50 MIC90 Range
Iso-Sensitest agar 8 32 4–32 64 128 16–128
Mueller-Hinton agar 16 64 4–64 32 64 16–128
Brain heart infusion agar 16 32 8–32 256 512 32–1024
a The control organism, E. faecalis NCTC 775, was consistently susceptible on all media tested (MIC, 0.5 mg/liter).
b Defined as having IS1542 and IS1216V-like insertions within the orf2-vanR and vcnX-vanY intergenic regions, respectively.
c Expressed in milligrams per liter.
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hybrid promoter results in the elevated teicoplanin resistance
conferred by nonprototype Tn1546 elements. The elevation in
teicoplanin resistance and not vancomycin resistance could
potentially reflect different abilities of the glycopeptide agents
to act against residual D-Ala-D-Ala-terminating precursors.
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